What is the story about?
What's Happening?
Blank Rome has announced the addition of Tom Sundlof as a partner in its life sciences industry team and corporate, M&A, and securities practice group in Washington, DC. Sundlof, who previously served in the FDA's Office of the Chief Counsel, will focus on regulatory, compliance, and enforcement matters for medical devices and other FDA-regulated products. His expertise will assist both domestic and international clients in navigating FDA regulations, from clinical trial design to post-market compliance.
Why It's Important?
The appointment of Tom Sundlof to Blank Rome's life sciences team strengthens the firm's capabilities in handling complex regulatory and compliance issues. His experience with the FDA provides valuable insights into the agency's operations and regulatory landscape, benefiting clients in the medical device and pharmaceutical sectors. This move reflects the growing importance of regulatory expertise in the life sciences industry, as companies face increasing scrutiny and evolving regulations. Sundlof's role will be crucial in helping clients achieve compliance and mitigate risks associated with FDA oversight.
AI Generated Content
Do you find this article useful?
